Tuis0L8 • FRA
add
Lantheus Holdings Inc
Vorige sluiting
€49,11
Dagwisseling
€48,88 - €48,88
Jaarwisseling
€41,91 - €106,75
Markkapitalisasie
3,84 mjd USD
Gemiddelde volume
28,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 378,04 m | -4,07% |
Bedryfskoste | 153,04 m | 0,00% |
Netto inkomste | 78,76 m | 26,87% |
Netto winsgrens | 20,83 | 32,25% |
Wins per aandeel | 1,57 | -12,78% |
EBITDA | 101,20 m | -13,91% |
Effektiewe belastingkoers | 24,65% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 695,57 m | -8,12% |
Totale bates | 2,12 mjd | 9,09% |
Totale aanspreeklikheid | 949,29 m | 3,96% |
Totale ekwiteit | 1,17 mjd | — |
Uitstaande aandele | 67,99 m | — |
Prys om te bespreek | 2,86 | — |
Opbrengs op bates | 10,54% | — |
Opbrengs op kapitaal | 12,35% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 78,76 m | 26,87% |
Kontant van bedrywe | 87,11 m | 2,82% |
Kontant van beleggings | -232,47 m | -415,62% |
Kontant van finansiering | -98,41 m | -99 507,07% |
Netto kontantverandering | -242,95 m | -726,97% |
Beskikbare kontantvloei | 86,28 m | 164,00% |
Meer oor
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.
Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
Gestig
1956
Webwerf
Werknemers
808